AI assistant
Sending…
HARROW, INC. — Director's Dealing 2014
Sep 9, 2014
31774_dirs_2014-09-08_a868fe38-6f06-447c-8373-4da79c16622a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2014-09-04
Reporting Person: Nelson William H. (Director)
More from HARROW, INC.
Report Publication Announcement
2026
Jun 3
Major Shareholding Notification
2026
Mar 27
Capital/Financing Update
2026
Mar 24
Capital/Financing Update
2026
Mar 24
Director's Dealing
2026
Mar 3
Annual Report
2026
Mar 2
Earnings Release
2026
Mar 2
Regulatory Filings
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2